Literature DB >> 11723592

Does raloxifene reduce risk of vertebral fractures? Is this another, brighter way to treat osteoporosis?

S Hathirat1, M F Evans.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11723592      PMCID: PMC2018437     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  9 in total

1.  Therapy for fracture prevention.

Authors:  M R McClung
Journal:  JAMA       Date:  1999-08-18       Impact factor: 56.272

2.  Does raloxifene reduce postmenopausal women's risk of breast cancer?

Authors:  R K Han; N Pimlott; R Heisey
Journal:  Can Fam Physician       Date:  2000-01       Impact factor: 3.275

3.  Raloxifene: designer estrogen for preventing postmenopausal osteoporosis.

Authors:  L Park; M F Evans
Journal:  Can Fam Physician       Date:  1999-05       Impact factor: 3.275

4.  Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older.

Authors:  B Dawson-Hughes; S S Harris; E A Krall; G E Dallal
Journal:  N Engl J Med       Date:  1997-09-04       Impact factor: 91.245

Review 5.  The role of estrogen in the prevention of osteoporosis.

Authors:  R Lindsay
Journal:  Endocrinol Metab Clin North Am       Date:  1998-06       Impact factor: 4.741

6.  Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women.

Authors:  P D Delmas; N H Bjarnason; B H Mitlak; A C Ravoux; A S Shah; W J Huster; M Draper; C Christiansen
Journal:  N Engl J Med       Date:  1997-12-04       Impact factor: 91.245

7.  Correcting calcium nutritional deficiency prevents spine fractures in elderly women.

Authors:  R R Recker; S Hinders; K M Davies; R P Heaney; M R Stegman; J M Lappe; D B Kimmel
Journal:  J Bone Miner Res       Date:  1996-12       Impact factor: 6.741

8.  Vertebral fractures and mortality in older women: a prospective study. Study of Osteoporotic Fractures Research Group.

Authors:  D M Kado; W S Browner; L Palermo; M C Nevitt; H K Genant; S R Cummings
Journal:  Arch Intern Med       Date:  1999-06-14

9.  The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation.

Authors:  S R Cummings; S Eckert; K A Krueger; D Grady; T J Powles; J A Cauley; L Norton; T Nickelsen; N H Bjarnason; M Morrow; M E Lippman; D Black; J E Glusman; A Costa; V C Jordan
Journal:  JAMA       Date:  1999-06-16       Impact factor: 56.272

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.